PET–CT Imaging of Lung Cancer: The Current Status and Future Potentials

  • Sunita Sonavane
  • Sandip Basu


Lung cancer is the principal cause of cancer death worldwide; overall, 5-year survival of patients even with limited disease and resectable tumor is 35–40 %, making lung cancer one of the most important public health problems. Majority of patients die within 2 years of diagnosis. At the time of diagnosis, frequently, the disease is found to have spread beyond the primary site. Early localized lung cancer is treated with surgery with or without adjuvant chemotherapy; patients with positive ipsilateral mediastinal lymphadenopathy are treated with neoadjuvant chemotherapy followed by surgery, while more advanced cases are treated with palliative chemotherapy with or without radiotherapy.


Lung Cancer Carcinoid Tumor Recurrent Laryngeal Nerve Palsy Solitary Pulmonary Nodule Atypical Carcinoid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

For Further Reading

  1. 1.
    Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86.PubMedCrossRefGoogle Scholar
  2. 2.
    Buck AK, Herrmann K, Schreyögg J. PET-CT for staging lung cancer: costly or cost-saving? Eur J Nucl Med Mol Imaging. 2011;38:799–801.PubMedCrossRefGoogle Scholar
  3. 3.
    De Wever W, Ceyssens S, Mortelmans L, Stroobants S, Marchal G, Bogaert J, et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol. 2007;17:23–32.PubMedCrossRefGoogle Scholar
  4. 4.
    Kim SK, Allen Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al. Accuracy of PET-CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007;48:214–20.PubMedGoogle Scholar
  5. 5.
    Lynch TB. Textbook of PET-CT in clinical practice. Springer-Verlag, Berlin/Heidelberg/New York; 2007. p. 16–47.Google Scholar
  6. 6.
    Mac Manus MP, Hicks RJ. Impact of PET on radiation therapy planning in lung cancer. Radiol Clin North Am. 2007;45:627–38.PubMedCrossRefGoogle Scholar
  7. 7.
    Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008;49:1804–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Yamamoto Y, Kameyama R, Murota M, Bandoh S, Ishii T, Nishiyama Y. Early assessment of therapeutic response using FDG PET in small cell lung cancer. Mol Imaging Biol. 2009;11:467–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Radiation Medicine Centre, Bhabha Atomic Research CentreTata Memorial Hospital AnnexeMumbaiIndia
  2. 2.Radiation Medicine Centre, Bhabha Atomic Research CentreTata Memorial Hospital AnnexeMumbaiIndia

Personalised recommendations